Sabeluzole (R-58,735) is a
nootropic and
neuroprotective drug which was originally developed for the treatment of
Alzheimer's disease
Alzheimer's disease (AD) is a neurodegeneration, neurodegenerative disease that usually starts slowly and progressively worsens. It is the cause of 60–70% of cases of dementia. The most common early symptom is difficulty in short-term me ...
,
and has subsequently been researched for other applications such as
sleep apnoea.
It acts primarily as an
NMDA antagonist,
but other
mechanisms of action may also be important.
See also
*
Memantine
References
NMDA receptor antagonists
4-Fluorophenyl compounds
Phenol ethers
Secondary alcohols
Piperidines
Benzothiazoles
{{nervous-system-drug-stub